
    
      This study will evaluate the changes of different types of biomarkers before and after
      successful percutaneous implantation of an LAA occlusion device.

      Biomarker evaluation will focus on blood derived biomarkers including neurohormones,
      proteins, cytokines, microRNAs and metabolomics.
    
  